Editorial
Expanding Inclusivity: Tranexamic Acid for the Treatment of Melasma in Males
Journal of Drugs in Dermatology · 2024
DOI: 10.36849/jdd.7844 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Drugs in Dermatology, 2024. Verfasst von Nicole E Chin und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Tranexamic Acid, Melanosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Tranexamic AcidMelanosisMaleHumansAdministration, CutaneousTreatment Outcome
Substanzen
Tranexamic Acid
Zitieren
APA
Chin, N. E., & Austin, A. H. (2024). Expanding Inclusivity: Tranexamic Acid for the Treatment of Melasma in Males. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.7844
Vancouver
Chin NE, Austin AH. Expanding Inclusivity: Tranexamic Acid for the Treatment of Melasma in Males. Journal of Drugs in Dermatology. 2024. doi:10.36849/jdd.7844
BibTeX
@article{Chin2024,
author = {Chin, Nicole E and Austin, Andrea Hui},
title = {Expanding Inclusivity: Tranexamic Acid for the Treatment of Melasma in Males},
journal = {Journal of Drugs in Dermatology},
year = {2024},
doi = {10.36849/jdd.7844}
}
EUVIMED